Cencora Inc
NYSE:COR

Watchlist Manager
Cencora Inc Logo
Cencora Inc
NYSE:COR
Watchlist
Price: 338.22 USD -0.42% Market Closed
Market Cap: 65.6B USD

During the last 3 months Cencora Inc insiders have not bought any shares, and sold 14.7m USD worth of shares. The stock price has increased by 14% over this period (open performance analysis).

The last transaction was made on Nov 18, 2025 by Mauch Robert P. , who sold 1.9m USD worth of COR shares.

Last Transactions:
Mauch Robert P.
$-1.9m
Mauch Robert P.
$-1.7m
Campbell Elizabeth S
$-590.8k
Mauch Robert P.
$-1.5m
Collis Steven H
$-9.1m
Collis Steven H
$-4.2m
Mauch Robert P.
$-1.5m
Collis Steven H
$-4.3m
Mauch Robert P.
$-1.5m
Collis Steven H
$-4.3m
Battaglia Silvana
$-1.2m
Mauch Robert P.
$-1.5m
Krikorian Lazarus
$-864.6k
Collis Steven H
$-4.3m
Mauch Robert P.
$-1.4m
Greenberg Lon R
$-837.2k
Collis Steven H
$-4.1m
Mauch Robert P.
$-1.4m
Collis Steven H
$-3.4m
Campbell Elizabeth S
$-570.6k
Mauch Robert P.
$-841.8k
Krikorian Lazarus
$-520.1k
Mauch Robert P.
$-444.7k
Collis Steven H
$-502.2k
Battaglia Silvana
$-1.2m
Walgreens Boots Alliance, Inc.
$-264.5m
Battaglia Silvana
$-383.8k
Krikorian Lazarus
$-454.8k
Collis Steven H
$-12.2m
Collis Steven H
$-5.2m
Collis Steven H
$-5.1m
Collis Steven H
$-5.2m
View All Transactions

During the last 3 months Cencora Inc insiders have not bought any shares, and sold 14.7m USD worth of shares. The stock price has increased by 14% over this period (open performance analysis).

The last transaction was made on Nov 18, 2025 by Mauch Robert P. , who sold 1.9m USD worth of COR shares.

Sold
0-3
months
14.7m USD
3
3-6
months
18.4m USD
3
6-9
months
18.3m USD
5
9-12
months
267.1m USD
4
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Cencora Inc
Insider Trading Chart

Cencora Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Cencora Inc
Last Insider Transactions

Global
Insiders Monitor

Cencora Inc
Glance View

Cencora Inc., once known as AmerisourceBergen, stands as a pivotal player in the healthcare landscape, sculpting pathways for the seamless distribution of pharmaceuticals across the globe. Born from a merger of AmeriSource Health Corporation and Bergen Brunswig Corporation in 2001, the company carved its identity by building extensive networks that bind drug manufacturers, pharmacies, and healthcare providers together into a cohesive chain. This intricate web ensures that pharmaceutical products, ranging from common prescriptions to specialized drugs, reach their destinations efficiently and securely. Cencora's proficiency lies not just in logistics but in its ability to adapt and innovate within rigid regulatory frameworks, ensuring its clients navigate the complexities of compliance while focusing on patient care. In terms of profitability, Cencora thrives on its vast and exponentially growing distribution channels, earning a steady stream of revenue through service fees and percentage fees tied to the value of distributed goods. Moreover, the company's integrated service offerings, such as consulting, analytics, and supply chain management solutions, provide additional avenues of income by addressing the strategic needs of its clientele. This dual approach of logistics and consultancy allows Cencora not only to serve as a conduit for drug distribution but also as a trusted advisor in a healthcare sphere that is increasingly data-driven and efficiency-focused. Through its multi-faceted business model, Cencora secures its foundation in a volatile industry, supporting the balance of patient needs, market demands, and regulatory compliance.

COR Intrinsic Value
543.27 USD
Undervaluation 38%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top